-
Although mortality rates for sepsis have improved over the past two decades, its increasing incidence has resulted in a tripling of the number of in-hospital deaths related to sepsis over the same time period.
-
Medications for Risk Reduction of Breast Cancer in Women
-
Using the Critical-Care Pain Observation Tool to routinely assess pain in non-verbal ICU patients improved both the frequency of documented pain assessments and the administration of analgesics in two Canadian ICUs.
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
-
LAP2 was a phase 3 clinical trial to assess the non-inferiority of laparoscopy compared with laparotomy for recurrence of uterine cancer after surgical staging.
-
During the past few months, there has been a pleth-ora of articles published with important clinical implications, and I have found it difficult to pick just one to review.
-
Although the levonorgestrel intrauterine system (LNG IUS) has been shown to be an effective treatment for heavy menstrual bleeding (HMB), previous clinical trials included rigorous criteria focused primarily on measuring the severity of bleeding.
-
In this issue: Calcium supplementation in women; type 2 diabetes treatments and pancreatitis risk; treating chronic idiopathic urticaria; rivaroxaban and VTE; and FDA actions.
-
Tubal sterilization is a highly effective, permanent, and safe method of contraception. Tubal sterilization is the second most common method of contraception used by women in the United States and the most common among women over 30 years of age.
-
This Phase 1 clinical trial evaluated the safety and pharmacokinetics of intraventricular immune-chemotherapy with twice weekly rituximab (10 mg and 25 mg) and methotrexate in 14 patients with recurrent central nervous system lymphoma (primary or secondary).